Salarius Pharmaceuticals, Inc. (SLRX)
NASDAQ: SLRX · Real-Time Price · USD
0.825
-0.046 (-5.23%)
At close: Dec 5, 2025, 4:00 PM EST
0.880
+0.055 (6.67%)
After-hours: Dec 5, 2025, 7:59 PM EST
Salarius Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Cash & Equivalents | 4.81 | 2.43 | 5.9 | 12.11 | 29.21 | 11.12 | |
| Cash & Short-Term Investments | 4.81 | 2.43 | 5.9 | 12.11 | 29.21 | 11.12 | |
| Cash Growth | 46.46% | -58.74% | -51.27% | -58.56% | 162.75% | 197.38% | |
| Receivables | 0.2 | - | - | 1.61 | - | 3.86 | |
| Prepaid Expenses | 0.15 | 0.33 | 0.62 | 0.8 | 0.95 | 0.82 | |
| Other Current Assets | 0.9 | 0.22 | - | - | - | - | |
| Total Current Assets | 6.06 | 2.99 | 6.52 | 14.52 | 30.16 | 15.8 | |
| Property, Plant & Equipment | - | - | - | - | - | 0.02 | |
| Goodwill | - | - | - | - | 8.87 | 8.87 | |
| Long-Term Accounts Receivable | - | - | - | - | 1.61 | - | |
| Other Long-Term Assets | 0.03 | 0.04 | 0.07 | 0.13 | 0.19 | 0.25 | |
| Accounts Payable | 1.1 | 0.94 | 0.6 | 2.86 | 1.54 | 1.85 | |
| Accrued Expenses | 0.74 | 0.35 | 0.41 | 1.41 | 0.57 | 0.38 | |
| Short-Term Debt | - | 0.22 | 0.29 | - | - | 0.48 | |
| Other Current Liabilities | - | - | - | - | - | 0.06 | |
| Total Current Liabilities | 1.85 | 1.51 | 1.3 | 4.27 | 2.11 | 2.77 | |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| Additional Paid-In Capital | 89.71 | 83.44 | 81.64 | 74.19 | 70.92 | 41.59 | |
| Retained Earnings | -85.46 | -81.92 | -76.35 | -63.81 | -32.2 | -19.43 | |
| Total Common Equity | 4.25 | 1.51 | 5.29 | 10.38 | 38.72 | 22.16 | |
| Total Liabilities & Equity | 6.1 | 3.02 | 6.59 | 14.65 | 40.83 | 24.93 | |
| Total Debt | - | 0.22 | 0.29 | - | - | 0.48 | |
| Net Cash (Debt) | 4.81 | 2.21 | 5.61 | 12.11 | 29.21 | 10.64 | |
| Net Cash Growth | 62.75% | -60.56% | -53.66% | -58.56% | 174.53% | 228.79% | |
| Filing Date Shares Outstanding | 5.86 | - | - | - | 0.02 | 0.01 | |
| Total Common Shares Outstanding | 0.94 | - | - | - | 0.02 | - | |
| Working Capital | 4.22 | 1.48 | 5.22 | 10.25 | 28.05 | 13.02 | |
| Book Value Per Share | 4.50 | - | - | - | 2567.67 | - | |
| Tangible Book Value | 4.25 | 1.51 | 5.29 | 10.38 | 29.86 | 13.29 | |
| Tangible Book Value Per Share | 4.50 | - | - | - | 1979.78 | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.